Clinical Trial Update: Interrupting Sedentary Time to Improve Cardiometabolic Health and Toxicity in Patients With Lymphoma Receiving Chemotherapy: The iSTAND Trial [NA]

View source ↗

Summary

Clinical trial evaluating whether interrupting sedentary time can improve cardiometabolic health and chemotherapy-related toxicity in patients with lymphoma; th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hodgkin Lymphoma
• Non-hodgkin Lymphoma

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Lymphoma, Lymphoma, Hodgkin | NA | Status: RECRUITING